Section 58-2.19 - Records to be kept when derivatives are infused

58-2.19 Records to be kept when derivatives are infused. The following information shall be included on the recipient's chart or in records maintained in the blood bank or pharmacy:
(a) product name, manufacturer, lot number, and expiration date;

(b) documentation of visual inspection prior to infusion;

(c) name of person administering the product;

(d) documentation of identification of the recipient;

(e) date of infusion and quantity of material infused; and

(f) description of any adverse reaction and the results of related investigation.

Effective Date: 
Sunday, September 27, 2015
Doc Status: 
Complete